Dr Peter Bennett

BVSc FANZCVS (Canine Medicine)
DACVIM (Oncology, Small Animal Internal Medicine)
Clinical Specialist in Oncology

B10 - Evelyn Williams Building
The University of Sydney


Biographical details

Dr Bennett is a graduate of the University of Melbourne. After time in general practice he completed residency training in small animal medicine in 1999 and then joined the faculty of Purdue University in Indiana where he was trained in oncology. He is a Fellow of the Australian and New Zealand College of Veterinary Scientists (Canine Medicine) and a Diplomate of the American College of Veterinary Internal Medicine (Oncology, Small Animal Internal Medicine).

Associations

Peter is a member of a consensus statement committee for the American College on Veterinary Internal Medicine on the topic of Chemotherapy Safety

Selected grants

2014

  • Efficacy of a personalised tumour vaccine to treat dogs with cancer; Weir C, Bennett P; Canine Research foundation/Research Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Brockley, L., Cooper, M., Bennett, P. (2013). Malignant melonoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival. New Zealand Veterinary Journal, 61(1), 25-31. [More Information]
  • Brockley, L., Heading, K., Jardine, J., Moore, P., Bennett, P. (2012). Polyostotic lymphoma with multiple pathological fractures in a six-month-old cat. Journal of Feline Medicine and Surgery, 14(4), 285-291. [More Information]
  • Hambrook, L., Bennett, P. (2012). The effect of pimobendan on the clinical outcome and survival of cats with non taurine responsive dilated cardiomyopathy. Journal of Feline Medicine and Surgery, 14(4), 233-239. [More Information]
  • Brockley, L., Bennett, P., Cooper, M. (2012). Use of chemotherapy for the management of carcinoma of prostate in four dogs. Australian Veterinary Practitioner, 42(1), 194-199.
  • Heading, K., Brockley, L., Bennett, P. (2011). CCNU (Lomustine) toxicity in dogs - a retrospective study (2002-2007). Australian Veterinary Journal, 89(4), 109-116. [More Information]
  • Heading, K., Nicoll, R., Bennett, P. (2011). Intra-Ventricular Pneumocephalus and Intra-Nasal Meningoencephalocele following Dorsal Rhinotomy. Australian Veterinary Practitioner, 41(2), 2-8.
  • Brown, J., Allan, G., Bennett, P. (2011). Magnetic resonance imaging findings, treatment and survival in dogs with central nervous system disease and inflammatory cerebrospinal fluid. Australian Veterinary Practitioner, 41(4), 152-158.
  • Brockley, L., Heading, K., Bennett, P. (2010). Long term chemotherapy for disseminated undifferentiated carcinoma of unknown origin. Australian Veterinary Practitioner, 40(3), 103-108.
  • Heading, K., Bennett, P. (2010). Presumed Immune-mediated Pancytopaenia in a cat. Australian Veterinary Practitioner, 40(2), 46-52.
  • Cooper, M., Tsai, X., Bennett, P. (2009). Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases. Veterinary and Comparative Oncology, 7(3), 196-206. [More Information]

Conferences

  • Bennett, P. (2013). HOT TOPICS FROM THE ONCOLOGY MEETINGS. Australian and New Zealand College of Veterinary Scientists Science week.
  • Bennett, P. (2013). Invited plenary speaker: Training programs of excellence: Individual or Institution? Australian and New Zealand College of Veterinary Scientists Science week.
  • Bennett, P. (2013). Metronomic Chemotherapy. Australian and New Zealand College of Veterinary Scientists Science week.
  • Bennett, P. (2013). The role of PET/CT in Oncology. Australian and New Zealand College of Veterinary Scientists Science week.

2013

  • Bennett, P. (2013). HOT TOPICS FROM THE ONCOLOGY MEETINGS. Australian and New Zealand College of Veterinary Scientists Science week.
  • Bennett, P. (2013). Invited plenary speaker: Training programs of excellence: Individual or Institution? Australian and New Zealand College of Veterinary Scientists Science week.
  • Brockley, L., Cooper, M., Bennett, P. (2013). Malignant melonoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival. New Zealand Veterinary Journal, 61(1), 25-31. [More Information]
  • Bennett, P. (2013). Metronomic Chemotherapy. Australian and New Zealand College of Veterinary Scientists Science week.
  • Bennett, P. (2013). The role of PET/CT in Oncology. Australian and New Zealand College of Veterinary Scientists Science week.

2012

  • Brockley, L., Heading, K., Jardine, J., Moore, P., Bennett, P. (2012). Polyostotic lymphoma with multiple pathological fractures in a six-month-old cat. Journal of Feline Medicine and Surgery, 14(4), 285-291. [More Information]
  • Hambrook, L., Bennett, P. (2012). The effect of pimobendan on the clinical outcome and survival of cats with non taurine responsive dilated cardiomyopathy. Journal of Feline Medicine and Surgery, 14(4), 233-239. [More Information]
  • Brockley, L., Bennett, P., Cooper, M. (2012). Use of chemotherapy for the management of carcinoma of prostate in four dogs. Australian Veterinary Practitioner, 42(1), 194-199.

2011

  • Heading, K., Brockley, L., Bennett, P. (2011). CCNU (Lomustine) toxicity in dogs - a retrospective study (2002-2007). Australian Veterinary Journal, 89(4), 109-116. [More Information]
  • Heading, K., Nicoll, R., Bennett, P. (2011). Intra-Ventricular Pneumocephalus and Intra-Nasal Meningoencephalocele following Dorsal Rhinotomy. Australian Veterinary Practitioner, 41(2), 2-8.
  • Brown, J., Allan, G., Bennett, P. (2011). Magnetic resonance imaging findings, treatment and survival in dogs with central nervous system disease and inflammatory cerebrospinal fluid. Australian Veterinary Practitioner, 41(4), 152-158.

2010

  • Brockley, L., Heading, K., Bennett, P. (2010). Long term chemotherapy for disseminated undifferentiated carcinoma of unknown origin. Australian Veterinary Practitioner, 40(3), 103-108.
  • Heading, K., Bennett, P. (2010). Presumed Immune-mediated Pancytopaenia in a cat. Australian Veterinary Practitioner, 40(2), 46-52.

2009

  • Cooper, M., Tsai, X., Bennett, P. (2009). Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases. Veterinary and Comparative Oncology, 7(3), 196-206. [More Information]

For support on your academic profile contact .